Regulations.gov document
Final Closing Summary RE Hearing Involving the Obstetrics, Reproductive and Urologic Drugs…
Supporting & Related Material · FDA-2020-N-2029 · posted Oct 11, 2022
Key facts
| Document ID | FDA-2020-N-2029-0318 |
|---|---|
| Title | Final Closing Summary RE Hearing Involving the Obstetrics, Reproductive and Urologic Drugs Advisory Committee October 17-19, 2022 AGENDA |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2020-N-2029 |
| Posted | Oct 11, 2022 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: